Real-world treatment patterns, testing patterns, and clinical outcomes of first-line (1L) therapy for metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma (mGC/GEJC/EAC).
| Autor: | Kakehi, Sumie, Betts, Keith A., Nie, Xiaoyu, Kitchen, Sophie A., Ray, Saurabh |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p275-275, 185p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|